Cargando…
Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression
Ductal carcinoma in situ (DCIS) is a preinvasive form of breast cancer with a highly variable potential of becoming invasive and affecting mortality of the patients. Due to the lack of accurate markers of disease progression, many women with detected DCIS are currently overtreated. To distinguish th...
Autores principales: | Xu, Haifeng, Lien, Tonje, Bergholtz, Helga, Fleischer, Thomas, Djerroudi, Lounes, Vincent-Salomon, Anne, Sørlie, Therese, Aittokallio, Tero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209521/ https://www.ncbi.nlm.nih.gov/pubmed/34149812 http://dx.doi.org/10.3389/fgene.2021.670749 |
Ejemplares similares
-
Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors
por: Bergholtz, Helga, et al.
Publicado: (2022) -
Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020) -
Re-definition of claudin-low as a breast cancer phenotype
por: Fougner, Christian, et al.
Publicado: (2020) -
Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers
por: Fougner, Christian, et al.
Publicado: (2019) -
Comparable cancer‐relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer
por: Bergholtz, Helga, et al.
Publicado: (2020)